Tagged psychiatric

Michigan Psychological Care Launches New Psychiatry Services, No Waitlist, in Midland and Saint Johns, MI
Press Release

Michigan Psychological Care Launches New Psychiatry Services, No Waitlist, in Midland and Saint Johns, MI

 Read More
Press Release

Aurora Behavioral Health Announces Executive Leadership Promotions

 Read More
President and Co-Founder of the Schultes Center for Amazonian Ethnobotanical Research Joins Luminous Mind Inc. Scientific Advisor Network
Press Release

President and Co-Founder of the Schultes Center for Amazonian Ethnobotanical Research Joins Luminous Mind Inc. Scientific Advisor Network

 Luminous Mind Inc. scientists are focused on psychedelic and psychiatric treatments to enhance healthy brain function and to tackle Central Nervous System (CNS) disorders, including depression, PTSD, pain, anxiety, and addiction. These disorders are among the most serious challenges facing humanity today. Read More
Former Nature Genetics Chief Editor Joins the Research Team at Luminous Mind Inc. to Find Treatments for Psychiatric Illnesses
Press Release

Former Nature Genetics Chief Editor Joins the Research Team at Luminous Mind Inc. to Find Treatments for Psychiatric Illnesses

 Luminous Mind Inc. scientists are focused on psychedelic and psychiatric treatments to enhance healthy brain function and to tackle Central Nervous System (CNS) disorders, including depression, PTSD, pain, anxiety, and addiction. These disorders are among the most serious challenges facing humanity today. Read More
Medistar Corporation Announces Development of Medical Behavioral Hospital of Clear Lake
Press Release

Medistar Corporation Announces Development of Medical Behavioral Hospital of Clear Lake

 Read More
Watchdog Group, CCHR, to OBGYN Conference: Prevent Psychiatric Drugging of the Preborn
Press Release

Watchdog Group, CCHR, to OBGYN Conference: Prevent Psychiatric Drugging of the Preborn

 Warns That Antidepressants to Pregnant Mothers Can Cause Birth Defects Read More
Announcing New Services and Products for Depression Treatment
Press Release

Announcing New Services and Products for Depression Treatment

 Read More
Press Release

First Joint Cortex-Servier High-Impact Ampakine Compound Moves Into Phase I Clinical Studies

 France's largest privately held pharmaceutical company will move forward into Phase I clinical studies with the jointly-discovered High Impact AMPAKINE® compound S47445 (CX1632. Read More